We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MCD:NYSEMcDonald's Corporation Analysis

Data as of 2026-05-20 - not real-time

$280.80

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

McDonald’s shares are trading at $280.8, comfortably below the 20‑day (≈285.4), 50‑day (≈301.1) and 200‑day (≈308.3) simple moving averages, signaling a short‑term technical weakness. However, the RSI of 38 points to near‑oversold conditions and the MACD has turned bullish (line above signal, positive histogram), suggesting a potential bottom‑fade. The stock sits just above the identified support at $271.98 and below the next resistance at $304.9, with volume trending upward, which could fuel a modest bounce ahead of the Q1 earnings release (consensus $2.75 EPS, 8.9% revenue growth).
Fundamentally, the company delivers strong profitability (gross margin ~57%, operating margin ~44%) and solid cash generation (free cash flow ~$5.95 bn). The dividend yield of 2.65% with a 60% payout ratio remains sustainable, while revenue growth of ~9% and a forward PE of 19.7 indicate a healthy earnings outlook. Yet the DCF fair‑value estimate of $85.7 is dramatically lower than the current price, flagging the stock as significantly overvalued despite a consensus “Buy” from analysts.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Price below short‑term SMAs indicating bearish bias
  • Bullish MACD crossover and RSI near oversold suggest limited upside
  • Upcoming earnings could trigger a short‑term bounce

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong operating margins and free cash flow support dividend sustainability
  • Revenue growth ~9% and forward PE under 20 imply reasonable valuation relative to peers
  • Analyst consensus “Buy” with median price target ~327.5

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Brand longevity and expanding data‑driven real estate/AI initiatives
  • Dividend yield and payout ratio provide steady income
  • Significant overvaluation relative to DCF fair value limits upside potential

Key Metrics & Analysis

Financial Health

Revenue Growth9.40%
Profit Margin31.62%
P/E Ratio23.1
ROA13.56%
P/B Ratio-155.1
Op. Cash Flow$10.5B
Free Cash Flow$6.0B

Technical Analysis

TrendBearish
RSI38.5
Support$271.98
Resistance$304.89
MA 20$285.37
MA 50$301.05
MA 200$308.30
MACDBullish
VolumeIncreasing
Fear & Greed Index89.18

Valuation

Fair Value$85.65
Target Price$330.00
Upside/Downside17.52%
GradeOvervalued
TypeBlend
Dividend Yield2.65%

Risk Assessment

Beta0.12
Volatility19.50%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.